84
Participants
Start Date
April 30, 2016
Primary Completion Date
July 31, 2016
Study Completion Date
October 31, 2016
Naltrexone HCl/bupropion HCl
Naltrexone HCl/bupropion HCl extended-release tablet.
Placebo
Naltrexone/bupropion placebo-matching tablets.
Moxifloxacin
Moxifloxacin tablet.
Austin
Lead Sponsor
Orexigen Therapeutics, Inc
INDUSTRY